CompoAtlas

macérat-mère-gemmothérapie-aubépine

Food supplement declared in France, declaration No 2023-2-500, decision dated 9 February 2023

macérat-mère-gemmothérapie-aubépine, from amélie Grange, is a food supplement declared in France. Status: declared in France, may be marketed. Main ingredients: Crataegus monogyna 1 ml per day. None of the rules we check flags an issue with its declared composition.

Brand
not provided
Food business operator placing the product on the market
amélie Grange
Status
Declared in France, may be marketed: the authorities did not object to the declaration (this is neither an authorisation nor a safety assessment)
Form
Autre : gouttes
Daily dose
1ml
Directions for use
5 à 20 gouttes par jour en 1 à 3 prises dans un fond de verre d'eau en dehors des repas
Not recommended (according to the manufacturer)
Breastfeeding women, Young children (aged 1 to 3), Pregnant women

Declaration 269638, procedure Article 15. Compl'Alim, food supplement declarations (France), retrieved 15 November 2026.

Declared composition

Plants

PlantPartPreparationPer day
Crataegus monogyna Jacq.Feuille (bourgeon)Macérât hydroglycériné1 ml

Additives

E422

Other ingredients

Alcool, eau de source

List from the declaration, administrative decision dated (Compl'Alim, food supplement declarations (France)).

Photograph the packaging

Label warnings

Demander l'avis de votre médecin.Ne pas utiliser sans avis médical, notamment pour les personnes recevant déjà un traitement pour la tension ou à problème cardiaque.Déconseillé aux enfants en bas âge , aux femmes enceintes et allaitantes.Ne pas dépasser la dose journalière recommandée. Tenir hors de portée des jeunes enfants. ne peut pas se substituer à une alimentation équilibrée. Agiter avant emploi.

Regulatory points

None of the rules we check applies to the declared ingredients.

This information reproduces the manufacturer's declaration to the administration (DGAL). It does not say whether the product is effective and does not replace advice from a doctor or pharmacist, particularly during pregnancy or when taking medication.

Official warnings (Health Canada)

Health Canada publishes warnings on these ingredients:

  • Crataegus monogyna Jacq.
    Read the warning, when it applies and the studies cited

    Hawthorn

    Route of administration: Oral (ESCOP 2009; Bradley 2006; Mills and Bone 2000)

    Cautions and warnings

    Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms persist or worsen.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are taking cardiac glycosides (e.g., digoxin) or blood pressure or heart medications (Brinker 2010; Bradley 2006).

    Sources cited by Health Canada (2)
    • Bradley PR, editor. British Herbal Compendium: A Handbook of Scientific Information on Widely Used Plant Drugs, Volume 2. Bournemouth (GB): British Herbal Medicine Association; 2006.
    • Brinker F. Herb Contraindications and Drug Interactions, 4th edition. Sandy (OR): Eclectic Medical Publications; 2010.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you have chest pain, irregular heartbeat, or shortness of breath.

    Health Canada monograph dated 31 July 2026

They concern the ingredient, not this product or its dose. They do not replace medical advice.

Is something on this product wrong or out of date, whether you are a reader or the brand? Write to contact@compoatlas.com: every correction is published in the corrections log.

Cite this page: CompoAtlas, “macérat-mère-gemmothérapie-aubépine: composition and regulation”, https://compoatlas.com/en/supplements/products/269638-macerat-mere-gemmotherapie-aubepine, updated 15 November 2026.

List recorded in 2023. Photograph the packaging to check whether it has changed.

Enter to analyse, Shift+Enter for a new line